Skip to main content
. Author manuscript; available in PMC: 2016 Mar 21.
Published in final edited form as: Lancet. 2015 Jan 13;385(9973):1107–1113. doi: 10.1016/S0140-6736(14)61228-9

Figure 2. Decline in Median HCV Viral Load Day 0–28.

Figure 2

Decline in HCV VL after initiation of study drugs is shown. There was a significant difference in HCV RNA at Day 7, 14 and 28 for subjects who received sofosbuvir, ledipasvir and GS-9451 (green) compared to those who received sofosbuvir, ledipasvir and GS-9669 (blue) or sofosbuvir and ledipasvir (red) (p<0.05).